Long-Term Pulmonary Outcomes Following E-Cigarette or Vaping Product Use-Associated Lung Injury (EVALI): A Systematic Review

Long-Term Pulmonary Outcomes Following E-Cigarette

Penulis

DOI:

https://doi.org/10.59747/hmry9n05

Kata Kunci:

Disease progression, EVALI, long-term outcomes, pulmonary function, Vaping product use-associated lung injury

Abstrak

Background: Electronic cigarette or vaping product use-associated lung injury (EVALI) emerged as a major public health concern during the 2019 outbreak in the United States, causing over 2,800 hospitalizations and 68 deaths. While acute manifestations are well described, evidence regarding long-term outcomes remains limited.

 

Objective: To systematically evaluate long-term pulmonary outcomes following EVALI, including pulmonary function, radiological findings, persistent symptoms, healthcare utilization, mortality, and quality of life.

 

Methods: This systematic review followed PRISMA 2020 guidelines and was prospectively registered in PROSPERO. PubMed, ScienceDirect, and Google Scholar were searched from inception to 12 June 2026. Studies reporting post-discharge outcomes in patients diagnosed with EVALI according to CDC criteria were included. Risk of bias was assessed using the Newcastle-Ottawa Scale and JBI Critical Appraisal Checklists. Due to substantial heterogeneity, findings were synthesized narratively.

 

Results: Of 1,045 records identified, 14 reports representing 13 unique cohorts were included. Nine studies with follow-up ≥3 months formed the primary synthesis. Persistent respiratory symptoms were reported in 45-48% of survivors at 12 months. Radiological abnormalities persisted in 33% of patients at one year, including focal scarring in 11%. Reduced diffusing capacity for carbon monoxide (DLCO) was consistently observed. Cognitive impairment, depression, and anxiety affected up to 46%, 59%, and 62% of survivors, respectively. Rehospitalization reached 24% at one year, while cumulative three-year mortality was 7.3%.

 

Conclusion: A subset of EVALI survivors experiences incomplete recovery, highlighting the need for long-term multidisciplinary follow-up and standardized prospective studies.

 

Referensi

Abdallah, B., Lee, H., Weerakoon, S.M., Messiah, S.E., Harrell, M.B., Rao, D.R., 2023. Clinical manifestations of EVALI in adolescents before and during the COVID-19 pandemic. Pediatr. Pulmonol. 58, 949–958. https://doi.org/10.1002/ppul.26283

Aberegg, S.K., Cirulis, M.M., Maddock, S.D., Freeman, A., Keenan, L.M., Pirozzi, C.S., Raman, S.M., Schroeder, J., Mann, H., Callahan, S.J., 2020. Clinical, Bronchoscopic, and Imaging Findings of e-Cigarette, or Vaping, Product Use-Associated Lung Injury among Patients Treated at an Academic Medical Center. JAMA Netw. Open 3. https://doi.org/10.1001/jamanetworkopen.2020.19176

Ahmad, M., Aftab, G., Rehman, S., Frenia, D., 2020. Long-term Impact of E-cigarette and Vaping Product Use-associated Lung Injury on Diffusing Capacity for Carbon Monoxide Values: A Case Series. Cureus. https://doi.org/10.7759/cureus.7002

Blagev, D.P., Callahan, S.J., Harris, D., Collingridge, D.S., Hopkins, R.O., Eve, J.R., Waddoups, L., Aston, V., Brown, S., Lanspa, M.J., 2022. Prospectively Assessed Long-Term Outcomes of Patients with E-Cigarette- or Vaping-associated Lung Injury. Ann. Am. Thorac. Soc. 19, 1892–1899. https://doi.org/10.1513/AnnalsATS.202201-049OC

Blagev, D.P., Eve, J., Collingridge, D.S., Harris, D., Callahan, S.J., Lanspa, M.J., 2026. Long term health outcomes for patients with E-cigarette or Vaping, Associated Lung Injury (EVALI) compared to matched control subjects who vape. BMC Pulm. Med. 26. https://doi.org/10.1186/s12890-026-04238-7

Blount, B.C., Karwowski, M.P., Shields, P.G., Morel-Espinosa, M., Valentin-Blasini, L., Gardner, M., Braselton, M., Brosius, C.R., Caron, K.T., Chambers, D., Corstvet, J., Cowan, E., De Jesús, V.R., Espinosa, P., Fernandez, C., Holder, C., Kuklenyik, Z., Kusovschi, J.D., Newman, C., Reis, G.B., Rees, J., Reese, C., Silva, L., Seyler, T., Song, M.-A., Sosnoff, C., Spitzer, C.R., Tevis, D., Wang, L., Watson, C., Wewers, M.D., Xia, B., Heitkemper, D.T., Ghinai, I., Layden, J., Briss, P., King, B.A., Delaney, L.J., Jones, C.M., Baldwin, G.T., Patel, A., Meaney-Delman, D., Rose, D., Krishnasamy, V., Barr, J.R., Thomas, J., Pirkle, J.L., 2020. Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI. New England Journal of Medicine 382, 697–705. https://doi.org/10.1056/nejmoa1916433

Burnham, E.L., Janssen, W.J., Riches, D.W.H., Moss, M., Downey, G.P., 2014. The fibroproliferative response in acute respiratory distress syndrome: Mechanisms and clinical significance. European Respiratory Journal. https://doi.org/10.1183/09031936.00196412

Butt, Y.M., Smith, M.L., Tazelaar, H.D., Vaszar, L.T., Swanson, K.L., 2019. Pathology of Vaping-Associated Lung Injury. New England Journal of Medicine 382, 903–916. https://doi.org/10.1056/nejmoa1911614

Carroll, B.J., Kim, M., Hemyari, A., Thakrar, P., Kump, T.E., Wade, T., De Vela, G., Hall, J., Diaz, C.D., D’Andrea, L.A., 2020. Impaired lung function following e-cigarette or vaping product use associated lung injury in the first cohort of hospitalized adolescents. Pediatr. Pulmonol. 55, 1712–1718. https://doi.org/10.1002/ppul.24787

Center for Disease Control and Prevention, 2020. Outbreak of Lung Injury Associated with the Use of E-Cigarette, or Vaping, Products [WWW Document]. URL https://archive.cdc.gov/#/details?url=https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html (accessed 6.10.26).

Cho, J.L., Villacreses, R., Nagpal, P., Guo, J., Pezzulo, A.A., Thurman, A.L., Hamzeh, N.Y., Blount, R.J., Fortis, S., Hoffman, E.A., Zabner, J., Comellas, A.P., 2022. Quantitative Chest CT Assessment of Small Airways Disease in Post-Acute SARS-CoV-2 Infection. Radiology 304, 185–192. https://doi.org/10.1148/radiol.212170

Eddy, R.L., Serajeddini, H., Knipping, D., Landman, S.T., Bosma, K.J., Mackenzie, C.A., Dhaliwal, I., Parraga, G., 2020. Pulmonary Functional MRI and CT in a Survivor of Bronchiolitis and Respiratory Failure Caused by e-Cigarette Use. Chest 158, e147–e151. https://doi.org/10.1016/j.chest.2020.06.005

Herridge, M.S., Tansey, C.M., Matté, A., Tomlinson, G., Diaz-Granados, N., Cooper, A., Guest, C.B., David Mazer, C., Mehta, S., Stewart, T.E., Kudlow, P., Cook, D., Slutsky, A.S., Cheung, A.M., 2011. Functional Disability 5 Years after Acute Respiratory Distress Syndrome, n engl j med.

Krishnasamy, V.P., Hallowell, B.D., Ko, J.Y., Board, A., Hartnett, K.P., Salvatore, P.P., Danielson, M., Kite-Powell, A., Twentyman, E., Kim, L., Cyrus, A., Wallace, M., Melstrom, P., Haag, B., King, B.A., Briss, P., Jones, C.M., Pollack, L.A., Ellington, S., 2020. Morbidity and Mortality Weekly Report Update: Characteristics of a Nationwide Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury-United States. US Department of Health and Human Services/Centers for Disease Control and Prevention.

Layden, J.E., Ghinai, I., Pray, I., Kimball, A., Layer, M., Tenforde, M.W., Navon, L., Hoots, B., Salvatore, P.P., Elderbrook, M., Haupt, T., Kanne, J., Patel, M.T., Saathoff-Huber, L., King, B.A., Schier, J.G., Mikosz, C.A., Meiman, J., 2020. Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin — Final Report. New England Journal of Medicine 382, 903–916. https://doi.org/10.1056/nejmoa1911614

Lee, S., Sayad, E., Yenduri, N.J., Wang, K.Y., Guilleman, P., Farber, H., 2021. Improvement in Pulmonary Function Following Discontinuation of Vaping or E-cigarette Use in Adolescents with EVALI. Pediatr. Allergy Immunol. Pulmonol. https://doi.org/10.22541/au.159604017.74993695

Needham, D.M., Davidson, J., Cohen, H., Hopkins, R.O., Weinert, C., Wunsch, H., Zawistowski, C., Bemis-Dougherty, A., Berney, S.C., Bienvenu, O.J., Brady, S.L., Brodsky, M.B., Denehy, L., Elliott, D., Flatley, C., Harabin, A.L., Jones, C., Louis, D., Meltzer, W., Muldoon, S.R., Palmer, J.B., Perme, C., Robinson, M., Schmidt, D.M., Scruth, E., Spill, G.R., Storey, C.P., Render, M., Votto, J., Harvey, M.A., 2012. Improving long-term outcomes after discharge from intensive care unit: Report from a stakeholders’ conference. Crit. Care Med. 40, 502–509. https://doi.org/10.1097/CCM.0b013e318232da75

Park, J.-A., Crotty Alexander, L.E., Christiani, D.C., 2026. Vaping and Lung Inflammation and Injury. Annual Review of Physiology Downloaded from www.annualreviews.org. Guest 25, 32. https://doi.org/10.1146/annurev-physiol-061121

Rebuli, M.E., Rose, J.J., Noel, A., Croft, D.P., Benowitz, N.L., Cohen, A.H., Crotty Alexander, L.E., Ewart, G., Goniewicz, M.L., Jaspers, I., Jordt, S.E., Kligerman, S., Larsen, B.T., Leigh, N., Loughlin, C.E., McConnell, R., McGraw, M.D., Melzer, A.C., Neptune, E.R., Nguyen, T.B., Penn, A.L., Pinkerton, K.E., Rahman, I., Upson, D., Witek, T.J., Twentyman, E.R.F., 2023. The E-cigarette or Vaping Product Use–Associated Lung Injury Epidemic: Pathogenesis, Management, and Future Directions An Official American Thoracic Society Workshop Report. Ann. Am. Thorac. Soc. 20, 1–17. https://doi.org/10.1513/AnnalsATS.202209-796ST

Ritzau Ishøj Nielsen, M., Jensen, J.U.S., Sivapalan, P., Perch, M., Møller-Pedersen, F., 2025. E-cigarette or vaping product use-associated lung injury (EVALI). A case report of a 19-year-old male in Denmark. Eur. Clin. Respir. J. 12. https://doi.org/10.1080/20018525.2024.2445868

Tannert Niang, K.M., Grasso, A.B., Debchoudhury, I., Bushman, D., Jasek, J.P., Fairclough, M.A., Van Oss, K.R., Chamany, S., LaSane, K.D., Franklin, S.M., Talati, A.K., 2025. Prospective follow-up of New York City residents with e-cigarette, or vaping product use-associated lung injury—2020–2021. PLoS One 20. https://doi.org/10.1371/journal.pone.0304918

Triantafyllou, G.A., Tiberio, P.J., Zou, R.H., Lynch, M.J., Kreit, J.W., McVerry, B.J., Morris, A., Rose, J.J., 2021. Long-term outcomes of EVALI: a 1-year retrospective study. Lancet Respir. Med. https://doi.org/10.1016/S2213-2600(21)00415-X

Wei, X., Iakovou, A., Makaryus, M.R., Khanijo, S., 2021. Pulmonary Function Testing in Patients With E-Cigarette, or Vaping, Product Use-Associated Lung Injury. Cureus. https://doi.org/10.7759/cureus.17019

Wu, C.H., Liao, T.Y., Chen, Y.H., Kuo, P.H., 2021. Treatment of electronic cigarette or vaping product use-associated lung injury (EVALI) by corticosteroid and low-dose pirfenidone: Report of a case. Respirol. Case Rep. 9. https://doi.org/10.1002/rcr2.845

Zhang, M.S., Nee, T., Lynch, M., Rose, J.J., Morris, A., Chandra, D., 2024. Disproportionate Use of the ED by Patients 3 Years After e-Cigarette or Vaping Use-Associated Lung Injury. Chest 166, 339–342. https://doi.org/10.1016/j.chest.2024.02.023

Diterbitkan

2026-11-20

Terbitan

Bagian

Scoping review/systematic review/meta-analysis

Kategori